EXE.TO vs. DXT.TO
EXE.TO (Extendicare Inc.) and DXT.TO (Dexterra Group Inc.) are both stocks. EXE.TO operates in Medical Care Facilities (Healthcare), while DXT.TO operates in Specialty Business Services (Industrials). Over the past 10 years, EXE.TO returned 22.41%/yr vs 7.72%/yr for DXT.TO. At a 0.13 correlation, their price movements are largely independent.
Performance
EXE.TO vs. DXT.TO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EXE.TO achieves a 55.68% return, which is significantly higher than DXT.TO's 12.80% return. Over the past 10 years, EXE.TO has outperformed DXT.TO with an annualized return of 22.41%, while DXT.TO has yielded a comparatively lower 7.72% annualized return.
EXE.TO
- 1D
- 0.37%
- 1M
- -1.27%
- YTD
- 55.68%
- 6M
- 45.62%
- 1Y
- 137.90%
- 3Y*
- 73.39%
- 5Y*
- 39.77%
- 10Y*
- 22.41%
DXT.TO
- 1D
- 1.48%
- 1M
- 3.66%
- YTD
- 12.80%
- 6M
- 10.53%
- 1Y
- 51.53%
- 3Y*
- 39.21%
- 5Y*
- 22.12%
- 10Y*
- 7.72%
EXE.TO vs. DXT.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EXE.TO Extendicare Inc. | 55.68% | 108.12% | 54.90% | 19.31% | -3.86% | 17.26% | -14.91% | 40.94% | -26.10% | -2.76% |
DXT.TO Dexterra Group Inc. | 12.80% | 55.32% | 43.20% | 11.05% | -31.72% | 38.36% | 8.40% | -30.88% | 17.73% | -20.59% |
Correlation
The correlation between EXE.TO and DXT.TO is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.05 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Nov 10, 2006 | 0.13 |
The correlation between EXE.TO and DXT.TO shifts across timeframes, from -0.11 (1 year) to 0.16 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
EXE.TO:
CA$3.18B
DXT.TO:
CA$829.70M
EXE.TO:
CA$1.37
DXT.TO:
CA$0.72
EXE.TO:
24.08
DXT.TO:
18.08
EXE.TO:
0.33
DXT.TO:
0.11
EXE.TO:
1.68
DXT.TO:
0.76
EXE.TO:
8.10
DXT.TO:
2.85
EXE.TO:
CA$1.75B
DXT.TO:
CA$1.08B
EXE.TO:
CA$553.60M
DXT.TO:
CA$161.12M
EXE.TO:
CA$205.13M
DXT.TO:
CA$113.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EXE.TO vs. DXT.TO — Risk / Return Rank
EXE.TO
DXT.TO
EXE.TO vs. DXT.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Extendicare Inc. (EXE.TO) and Dexterra Group Inc. (DXT.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EXE.TO | DXT.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.06 | ||
| Sortino ratioReturn per unit of downside risk | +3.05 | ||
| Omega ratioGain probability vs. loss probability | 1.72 | 1.37 | +0.35 |
| Calmar ratioReturn relative to maximum drawdown | 10.08 | 3.74 | +6.34 |
| Martin ratioReturn relative to average drawdown | 29.11 | 9.01 | +20.11 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EXE.TO | DXT.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 4.12 | 2.06 | +2.06 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.66 | 0.80 | +0.85 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.88 | 0.18 | +0.70 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.40 | 0.01 | +0.39 |
Drawdowns
EXE.TO vs. DXT.TO - Drawdown Comparison
The maximum EXE.TO drawdown since its inception was -79.65%, smaller than the maximum DXT.TO drawdown of -97.14%. Use the drawdown chart below to compare losses from any high point for EXE.TO and DXT.TO.
Loading charts...
Drawdown Indicators
| EXE.TO | DXT.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.65% | -97.14% | +17.49% |
Max Drawdown (1Y)Largest decline over 1 year | -13.76% | -13.84% | +0.08% |
Max Drawdown (3Y)Largest decline over 3 years | -22.07% | -13.91% | -8.16% |
Max Drawdown (5Y)Largest decline over 5 years | -22.07% | -44.49% | +22.42% |
Max Drawdown (10Y)Largest decline over 10 years | -46.29% | -91.68% | +45.39% |
Current DrawdownCurrent decline from peak | -3.75% | -62.28% | +58.53% |
Average DrawdownAverage peak-to-trough decline | -20.42% | -59.33% | +38.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.76% | 5.74% | -0.98% |
Volatility
EXE.TO vs. DXT.TO - Volatility Comparison
Extendicare Inc. (EXE.TO) has a higher volatility of 11.51% compared to Dexterra Group Inc. (DXT.TO) at 5.90%. This indicates that EXE.TO's price experiences larger fluctuations and is considered to be riskier than DXT.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EXE.TO | DXT.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.51% | 5.90% | +5.61% |
Volatility (6M)Calculated over the trailing 6-month period | 23.69% | 18.82% | +4.87% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.72% | 25.18% | +8.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.17% | 27.74% | -3.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.67% | 43.84% | -18.17% |
Dividends
EXE.TO vs. DXT.TO - Dividend Comparison
EXE.TO's dividend yield for the trailing twelve months is around 1.55%, less than DXT.TO's 2.98% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DXT.TO Dexterra Group Inc. | 2.98% | 3.22% | 4.49% | 6.08% | 6.35% | 3.78% | 2.31% | 1.30% | 0.89% | 1.04% | 0.82% | 2.48% |
EXE.TO Extendicare Inc. | 1.55% | 2.34% | 4.52% | 6.59% | 7.32% | 6.58% | 7.23% | 5.69% | 7.56% | 5.25% | 4.86% | 4.97% |
Financials
EXE.TO vs. DXT.TO - Financials Comparison
This section allows you to compare key financial metrics between Extendicare Inc. and Dexterra Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EXE.TO vs. DXT.TO - Profitability Comparison
EXE.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Extendicare Inc. reported a gross profit of 58.87M and revenue of 465.22M. Therefore, the gross margin over that period was 12.7%.
DXT.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dexterra Group Inc. reported a gross profit of 38.52M and revenue of 275.47M. Therefore, the gross margin over that period was 14.0%.
EXE.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Extendicare Inc. reported an operating income of 42.70M and revenue of 465.22M, resulting in an operating margin of 9.2%.
DXT.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dexterra Group Inc. reported an operating income of 15.71M and revenue of 275.47M, resulting in an operating margin of 5.7%.
EXE.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Extendicare Inc. reported a net income of 40.73M and revenue of 465.22M, resulting in a net margin of 8.8%.
DXT.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dexterra Group Inc. reported a net income of 13.52M and revenue of 275.47M, resulting in a net margin of 4.9%.
Frequently Asked Questions
EXE.TO and DXT.TO have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for EXE.TO and DXT.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer